The following adjustment was made today on Teva Pharmaceutical Industries Ltd (TEVA). All prices include IB commissions.
Criteria | Value |
Dividend Champions Status | Contender |
Years of Consecutive Dividend Increases | 12 |
Fair Value Estimate | $63.00 |
Target Buy Price | $45.00 |
Target Margin of Safety | 28.57% |
Actual Buy Price | $45.00 |
Actual Margin of Safety | 28.57% |
Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
11/3/2011 | TEVA | Continued Trade | STO 1 Jan12 45.00 Call @ 0.91 | | | $91.13 |
Current Position Summary
Cost Basis | ($4,500.00) |
Income Generated | $214.11 |
Percent Income Generated | 4.76% |
Annualized Income Generated | 7.18% |
Net Profit If Assigned | $214.11 |
Percent Return If Assigned | 4.76% |
Annualized Return If Assigned | 7.18% |
Days Held to Expiration | 242 days |
Trade History
Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
5/23/2011 | TEVA | CSP Margin Used | CSP 100 TEVA @ 45.00 | | ($4,500.00) | |
5/23/2011 | TEVA | Initial Put Option | STO 1 Sep11 45.00 Put @ 1.23 | Exercised | | $122.98 |
9/16/2011 | TEVA | CSP Margin Returned | CSP 100 TEVA @ -45.00 | | $4,500.00 | |
9/16/2011 | TEVA | Stock Assigned | EX 1 Sep11 45.00 Put @ -45.00 | | ($4,500.00) | |
11/3/2011 | TEVA | Continued Trade | STO 1 Jan12 45.00 Call @ 0.91 | | | $91.13 |
1/20/2012 | TEVA | | Totals | | ($4,500.00) | $214.11 |
DTE | 242 | | Percent Income/Annualized | | 4.76% | 7.18% |